Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing Escherichia coli -associated hemolytic uremic syndrome: a post hoc analysis of a phase 2 clinical trial
Puntos clave
To evaluate the effectiveness of serology as an early diagnostic tool for hemolytic uremic syndrome in pediatric patients.
Conducted a post hoc analysis of a phase 2 clinical trial.
Examined pediatric patients diagnosed with hemolytic uremic syndrome.
Utilized serological testing to assess diagnosis accuracy.
Serology demonstrated a strong predictive value for diagnosing hemolytic uremic syndrome.
Early detection through serology may improve management outcomes in affected children.
Resumen
This study was registered with ClinicalTrials.gov as NCT05569746.
Serology as an early diagnostic tool in pediatric patients with Shiga toxin-producing Escherichia coli -associated hemolytic uremic syndrome: a post hoc analysis of a phase 2 clinical trial | Synapse